Adaprolol
Alternative Names: Adaprolol maleate; CDDD 2803; CTD 90107; HGP 2; IDR 90107Latest Information Update: 23 May 2003
At a glance
- Originator Xenon Vision
- Class Antiglaucomas; Phenylacetates
- Mechanism of Action Beta adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Glaucoma
Most Recent Events
- 23 May 2003 Discontinued - Phase-II for Glaucoma in USA (Ophthalmic)
- 09 Sep 2002 No development reported - Phase-II for Glaucoma in USA (Ophthalmic)
- 02 Oct 2000 This ophthalmic formulation of adaprolol is available for licensing from Corporate Technology Development Inc. (http://www.corpdevelop.com)